211 related articles for article (PubMed ID: 35730319)
1. M
Zhang Y; Gao LX; Wang W; Zhang T; Dong FY; Ding WP
Cancer Sci; 2022 Sep; 113(9):3085-3096. PubMed ID: 35730319
[TBL] [Abstract][Full Text] [Related]
2. m
Wang X; Wu R; Liu Y; Zhao Y; Bi Z; Yao Y; Liu Q; Shi H; Wang F; Wang Y
Autophagy; 2020 Jul; 16(7):1221-1235. PubMed ID: 31451060
[TBL] [Abstract][Full Text] [Related]
3. Meclofenamic acid promotes cisplatin-induced acute kidney injury by inhibiting fat mass and obesity-associated protein-mediated m
Zhou P; Wu M; Ye C; Xu Q; Wang L
J Biol Chem; 2019 Nov; 294(45):16908-16917. PubMed ID: 31578283
[TBL] [Abstract][Full Text] [Related]
4. SBI0206965, a novel inhibitor of Ulk1, suppresses non-small cell lung cancer cell growth by modulating both autophagy and apoptosis pathways.
Tang F; Hu P; Yang Z; Xue C; Gong J; Sun S; Shi L; Zhang S; Li Z; Yang C; Zhang J; Xie C
Oncol Rep; 2017 Jun; 37(6):3449-3458. PubMed ID: 28498429
[TBL] [Abstract][Full Text] [Related]
5. Cobalt induces neurodegeneration through FTO-triggered autophagy impairment by targeting TSC1 in an m
Tang J; Zheng F; Liu X; Li Y; Guo Z; Lin X; Zhou J; Zhang Y; Yu G; Hu H; Shao W; Wu S; Li H
J Hazard Mater; 2023 Jul; 453():131354. PubMed ID: 37054644
[TBL] [Abstract][Full Text] [Related]
6. FTO facilitates cancer metastasis by modifying the m
Gao L; Wang A; Chen Y; Cai X; Li Y; Zhao J; Zhang Y; Zhang W; Zhu J; Zeng Y; Liu Z; Huang JA
Cell Commun Signal; 2023 Nov; 21(1):311. PubMed ID: 37919739
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of autophagy improves resistance and enhances sensitivity of gastric cancer cells to cisplatin.
Hou G; Bai Y; Jia A; Ren Y; Wang Y; Lu J; Wang P; Zhang J; Lu Z
Can J Physiol Pharmacol; 2020 Jul; 98(7):449-458. PubMed ID: 32058824
[TBL] [Abstract][Full Text] [Related]
8. N6-methyladenosine demethylase FTO enhances chemo-resistance in colorectal cancer through SIVA1-mediated apoptosis.
Lin Z; Wan AH; Sun L; Liang H; Niu Y; Deng Y; Yan S; Wang QP; Bu X; Zhang X; Hu K; Wan G; He W
Mol Ther; 2023 Feb; 31(2):517-534. PubMed ID: 36307991
[TBL] [Abstract][Full Text] [Related]
9. Fat mass and obesity-associated protein (FTO) mediated m
Wu X; Fang Y; Gu Y; Shen H; Xu Y; Xu T; Shi R; Xu D; Zhang J; Leng K; Shu Y; Ma P
Mol Biomed; 2024 Apr; 5(1):11. PubMed ID: 38556586
[TBL] [Abstract][Full Text] [Related]
10. Long non‑coding RNA LUCAT1 contributes to cisplatin resistance by regulating the miR‑514a‑3p/ULK1 axis in human non‑small cell lung cancer.
Shen Q; Xu Z; Xu S
Int J Oncol; 2020 Oct; 57(4):967-979. PubMed ID: 32945379
[TBL] [Abstract][Full Text] [Related]
11. Rational Design and Optimization of m
Huff S; Kummetha IR; Zhang L; Wang L; Bray W; Yin J; Kelley V; Wang Y; Rana TM
J Med Chem; 2022 Aug; 65(16):10920-10937. PubMed ID: 35939803
[TBL] [Abstract][Full Text] [Related]
12. N6-methyladenosine demethyltransferase FTO-mediated autophagy in malignant development of oral squamous cell carcinoma.
Wang F; Liao Y; Zhang M; Zhu Y; Wang W; Cai H; Liang J; Song F; Hou C; Huang S; Zhang Y; Wang C; Hou J
Oncogene; 2021 Jun; 40(22):3885-3898. PubMed ID: 33972683
[TBL] [Abstract][Full Text] [Related]
13. N6-methyladenosine demethylase FTO promotes growth and metastasis of gastric cancer via m
Zhou Y; Wang Q; Deng H; Xu B; Zhou Y; Liu J; Liu Y; Shi Y; Zheng X; Jiang J
Cell Death Dis; 2022 Jan; 13(1):72. PubMed ID: 35064107
[TBL] [Abstract][Full Text] [Related]
14. FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner.
Huang J; Sun W; Wang Z; Lv C; Zhang T; Zhang D; Dong W; Shao L; He L; Ji X; Zhang P; Zhang H
J Exp Clin Cancer Res; 2022 Jan; 41(1):42. PubMed ID: 35090515
[TBL] [Abstract][Full Text] [Related]
15. RNA N6-methyladenosine demethylase FTO promotes pancreatic cancer progression by inducing the autocrine activity of PDGFC in an m
Tan Z; Shi S; Xu J; Liu X; Lei Y; Zhang B; Hua J; Meng Q; Wang W; Yu X; Liang C
Oncogene; 2022 May; 41(20):2860-2872. PubMed ID: 35422475
[TBL] [Abstract][Full Text] [Related]
16. Omeprazole improves chemosensitivity of gastric cancer cells by m6A demethylase FTO-mediated activation of mTORC1 and DDIT3 up-regulation.
Feng S; Qiu G; Yang L; Feng L; Fan X; Ren F; Huang K; Chen Y
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33393595
[TBL] [Abstract][Full Text] [Related]
17. FTO regulates adipogenesis by controlling cell cycle progression via m
Wu R; Liu Y; Yao Y; Zhao Y; Bi Z; Jiang Q; Liu Q; Cai M; Wang F; Wang Y; Wang X
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Oct; 1863(10):1323-1330. PubMed ID: 30305247
[TBL] [Abstract][Full Text] [Related]
18. FTO regulates myoblast proliferation by controlling CCND1 expression in an m
Deng K; Zhang Z; Ren C; Liang Y; Gao X; Fan Y; Wang F
Exp Cell Res; 2021 Apr; 401(2):112524. PubMed ID: 33651996
[TBL] [Abstract][Full Text] [Related]
19. NR3C1/Glucocorticoid receptor activation promotes pancreatic β-cell autophagy overload in response to glucolipotoxicity.
Wu T; Shao Y; Li X; Wu T; Yu L; Liang J; Zhang Y; Wang J; Sun T; Zhu Y; Chang X; Wang S; Chen F; Han X
Autophagy; 2023 Sep; 19(9):2538-2557. PubMed ID: 37039556
[TBL] [Abstract][Full Text] [Related]
20. FTO demethylates m6A modifications in CDKAL1 mRNA and promotes gastric cancer chemoresistance by altering mitochondrial dynamics.
Liu N; Liu C; Wang Z; Wang L; Wang J; Kong J
Clin Exp Pharmacol Physiol; 2023 Apr; 50(4):307-315. PubMed ID: 36628934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
